Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis.
Karri V, Lin H, Velazquez J, Batajoo A, Parekh D, Stanton W, Abhyankar H, El-Mallawany NK, Agrusa J, Eckstein O, Gulati N, Schwartz J, Woods-Stafford W, Boyd J, Saha A, Allen CE, McClain KL. Karri V, et al. Br J Haematol. 2024 Mar 19. doi: 10.1111/bjh.19380. Online ahead of print. Br J Haematol. 2024. PMID: 38501390
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Parekh D, Lin H, Batajoo A, Peckham-Gregory E, Karri V, Stanton W, Scull B, Fleishmann R, El-Mallawany N, Eckstein OS, Prudowsky ZD, Gulati N, Agrusa JE, Ahmed AZ, Chu R, Dietz MS, Goldman SC, Hogarty MD, Imran H, Intzes S, Kim JM, Kopp LM, Levy CF, Neff P, Pillai PM, Sisk BA, Schiff DE, Trobaugh-Lotrario AD, Walkovich K, McClain KL, Allen CE. Parekh D, et al. Among authors: karri v. Br J Haematol. 2024 Mar 19. doi: 10.1111/bjh.19376. Online ahead of print. Br J Haematol. 2024. PMID: 38501389
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Wistinghausen B, Toner K, Barkauskas DA, Jerkins LP, Kinoshita H, Chansky P, Pezzella G, Saguilig L, Hayashi RJ, Abhyankar H, Scull B, Karri V, Tanna J, Hanley P, Hermiston ML, Allen CE, Bollard CM. Wistinghausen B, et al. Among authors: karri v. Blood Adv. 2024 Mar 12;8(5):1116-1127. doi: 10.1182/bloodadvances.2023010832. Blood Adv. 2024. PMID: 38163318 Free PMC article.
Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
Mude L, Jupudi S, Swaroop AK, Tallapaneni V, Karri VVSR. Mude L, et al. Among authors: karri vvsr. J Biomol Struct Dyn. 2024 Mar;42(5):2437-2448. doi: 10.1080/07391102.2023.2209666. Epub 2023 May 9. J Biomol Struct Dyn. 2024. PMID: 37160705
70 results